Terminated NA INTERVENTIONAL 1-arm NCT03145116

Clinical Safety and Efficacy of CT ASPHINA 509 Lenses (UVEA509)

Clinical Safety and Efficacy of Hydrophilic Acrylic Intraocular Lenses - Retro Prospective Study

Sponsor: Carl Zeiss Meditec AG

Conditions Cataract

Updated 7 times since 2017 Last updated: Jul 17, 2018 Started: Sep 22, 2017 Primary completion: Feb 5, 2018 Completion: Feb 5, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

recruitment rate

Other terminated trials from Carl Zeiss Meditec AG

More terminations from Carl Zeiss Meditec AG

Other Cataract trials with similar outcome

Browse all Cataract trials

This NA trial investigates Cataract and is currently terminated or withdrawn. Carl Zeiss Meditec AG leads this study, which shows 7 recorded versions since 2017 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Terminated NA
Jul 2024 — Sep 2024 [monthly]

Terminated NA
Jan 2021 — Jul 2024 [monthly]

Terminated NA
Aug 2018 — Jan 2021 [monthly]

Terminated NA

Status: Recruiting → Terminated
Jun 2018 — Aug 2018 [monthly]

Recruiting NA

▶ Show 2 earlier versions

Feb 2018 — Jun 2018 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting · Phase: PHASE4 → NA
Jul 2017 — Feb 2018 [monthly]

Not Yet Recruiting PHASE4

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Carl Zeiss Meditec AG

Data source: Carl Zeiss Meditec AG

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Ahaus, Germany